Unless stated all financials at 30 June 2026
£1.04bn
Net assets
170.6p
NAV per share
(1.7)%
NAV per share return in the 12 months
£867m
Value of life science portfolio
1.2%
Return from life science portfolio in the 12 months
£171m
Capital pool